does glp-1 really work GLP-1 Agonists - What is it?

GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1

Cigna will stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its employee health plan effective July 1, according to Reuters.

Weight-loss drugs like Wegovy and Zepbound changed obesity treatment almost overnight. For many patients, these medicines reduce appetite, slow stomach emptying, and help the body manage blood sugar and fullness more effectively.

Frontiers | Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database

Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications

Thinking about taking GLP-1 drugs for weight loss? Read this first. India's drug safety authorities have issued an urgent alert asking patients, healthcare professionals, and consumers to closely MONITOR and REPORT